We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Orly Vardeny

Orly Vardeny PharmD, MS

Minneapolis VA Center for Care Delivery and Outcomes Research, Associate Professor of Medicine, University of Minnesota, Minneapolis, MN

Disclosures

Dr. Vardeny is a Co-Principal Investigator of the NIH-funded clinical trial “Influenza Vaccine to Effectively Stop Cardio Thoracic Events and Decompensated Heart Failure (INVESTED)” and has received research funding from Sanofi-Pasteur.

Recent Contributions to PracticeUpdate:

  1. Influenza Vaccine and Risk of Death From Heart Failure